The Antiviral Activities of Human Interferons
人干扰素的抗病毒活性
基本信息
- 批准号:7964667
- 负责人:
- 金额:$ 41.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AftercareAntiviral AgentsAntiviral ResponseB-LymphocytesBinding SitesBiological AssayBiological ProcessBurkitt LymphomaCell LineCellsCo-ImmunoprecipitationsComplexDengueDengue VirusDiseaseFlavivirusGene ExpressionGene Expression Microarray AnalysisGene ProteinsGenesGrowthHumanHuman ActivitiesHybridsInfectionInterferon ActivationInterferon Alfa-2aInterferon Alfa-2bInterferon Alfa-2cInterferon Type IInterferon Type IIInterferon-alphaInterferonsKnowledgeLaboratoriesMediatingMusPlayPropertyProtein FamilyProteinsRNA InterferenceResistanceReverse Transcriptase Polymerase Chain ReactionRoleSamplingSignal TransductionSuspension substanceSuspensionsSystemTestingTimeVirusVirus ReplicationWestern BlottingWorkautocrinebasedesigngene inductionin vivointerestinterferon-stimulated gene factor 3neutralizing antibodyprotein functionresearch studyresponsetranscription factortrend
项目摘要
In summary, an MTT assay was developed for suspension cells in which we can test IFN antiproliferative as well as antiviral activities at the same time. Based on results from the above mentioned assay, we were able to perform treatment on Daudi cells under conditions of non-growth inhibition but antiviral protection, and non-antiviral protection. The analysis of samples after this treatment allowed us to more precisely identify genes associated with IFN-alpha antiviral activity. Based on microarray results there were 26 genes that are commonly and significantly different between an IFN concentration leading to AV protection versus a concentration not causing AV protection. Results from antiviral neutralizing experiments suggested the association of the identified genes and proteins with IFN AV activity. Thus, this work not only represents an example of how precise results from biological assays can help in the design of experiments leading to identification of functional genes and proteins to elucidate the IFN AV effect, but this is also to our knowledge the first study involving an analysis of AV associated genes on a B cell line.
With respect to the ISGF3 complex and IFN-gamma signaling, western blot analysis revealed that phosphorylated Stat1 (Y701, as a surrogate for IFN activation) peaked at 2h when treated with IFN-alpha, remaining at low levels for up to 48h. Cells treated with IFN-gamma showed the same trend until 15h, when an increase in pStat1 was detected by an additional signaling peak that continued through 24h. Gene expression microarray analysis following IFN-gamma treatment for 24h indicated increased levels of antiviral proteins normally associated with a type-1 IFN response, such as Mx1, PKR, and OAS1. Induction of these genes by autocrine type-I and type-III IFN signaling was ruled out using both neutralizing antibodies in biological assays and by qRT-PCR. Despite the absence of any other IFNs, the ISGF3 transcription factor complex was isolated by co-immunoprecipitation after IFN-gamma treatment for 24h. It is possible that induction of this transcription factor complex plays a role in transcribing antiviral genes and the subsequent protection from viruses mediated by IFN-gamma.
总之,我们开发了一种针对悬浮细胞的 MTT 测定法,我们可以同时测试 IFN 抗增殖和抗病毒活性。基于上述测定的结果,我们能够在非生长抑制但抗病毒保护和非抗病毒保护的条件下对Daudi细胞进行处理。治疗后的样本分析使我们能够更准确地识别与 IFN-α 抗病毒活性相关的基因。根据微阵列结果,导致 AV 保护的 IFN 浓度与不引起 AV 保护的浓度之间有 26 个基因存在常见且显着的差异。抗病毒中和实验的结果表明,已识别的基因和蛋白质与 IFN AV 活性相关。因此,这项工作不仅代表了生物测定的精确结果如何帮助设计实验,从而识别功能基因和蛋白质以阐明 IFN AV 效应,而且据我们所知,这也是第一项涉及B 细胞系上 AV 相关基因的分析。
关于 ISGF3 复合物和 IFN-γ 信号传导,蛋白质印迹分析显示,磷酸化 Stat1(Y701,作为 IFN 激活的替代物)在用 IFN-α 处理时在 2 小时达到峰值,并在长达 48 小时内保持低水平。 用 IFN-γ 处理的细胞在 15 小时之前表现出相同的趋势,此时通过持续到 24 小时的额外信号峰值检测到 pStat1 的增加。 IFN-γ 治疗 24 小时后的基因表达微阵列分析表明,通常与 1 型 IFN 反应相关的抗病毒蛋白(例如 Mx1、PKR 和 OAS1)水平升高。 使用生物测定中的中和抗体和 qRT-PCR 排除了自分泌 I 型和 III 型 IFN 信号传导对这些基因的诱导。 尽管不存在任何其他 IFN,但在 IFN-γ 处理 24 小时后,通过免疫共沉淀分离了 ISGF3 转录因子复合物。 这种转录因子复合物的诱导可能在抗病毒基因转录和随后的 IFN-γ 介导的病毒防护中发挥作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathryn Zoon其他文献
Kathryn Zoon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathryn Zoon', 18)}}的其他基金
Novel Human Interferons Produced by Protein Engineering
蛋白质工程生产的新型人类干扰素
- 批准号:
8336183 - 财政年份:
- 资助金额:
$ 41.55万 - 项目类别:
Novel Human Interferons Produced by Protein Engineering
蛋白质工程生产的新型人类干扰素
- 批准号:
8156962 - 财政年份:
- 资助金额:
$ 41.55万 - 项目类别:
Infectious Diseases and Allergy Scientific Education and Outreach
传染病和过敏科学教育和推广
- 批准号:
8556192 - 财政年份:
- 资助金额:
$ 41.55万 - 项目类别:
Infectious Diseases and Allergy Scientific Education and Outreach
传染病和过敏科学教育和推广
- 批准号:
7732697 - 财政年份:
- 资助金额:
$ 41.55万 - 项目类别:
Activation, Maintenance and Certification of Infectious Diseases Labs
传染病实验室的激活、维护和认证
- 批准号:
8556191 - 财政年份:
- 资助金额:
$ 41.55万 - 项目类别:
Infectious Diseases and Allergy Scientific Education and Outreach
传染病和过敏科学教育和推广
- 批准号:
8745810 - 财政年份:
- 资助金额:
$ 41.55万 - 项目类别:
相似国自然基金
基于激发植物免疫为导向的嘧啶酮类高效抗病毒剂设计合成及作用机制研究
- 批准号:21807037
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
云南地方晾晒烟中的内源性抗烟草花叶病毒活性成分研究
- 批准号:31860100
- 批准年份:2018
- 资助金额:41.0 万元
- 项目类别:地区科学基金项目
基于kealiinine类海洋生物碱的新型抗病毒剂的设计合成、构效关系及作用机制研究
- 批准号:21772145
- 批准年份:2017
- 资助金额:64.0 万元
- 项目类别:面上项目
两种植物中抗烟草花叶病毒先导化合物的结构优化、构效关系及作用机制研究
- 批准号:31760089
- 批准年份:2017
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
生态农药的分子设计与作用机制
- 批准号:21732002
- 批准年份:2017
- 资助金额:300.0 万元
- 项目类别:重点项目
相似海外基金
First-in-human study of a potent anti-HBsAg neutralizing antibody
强效抗 HBsAg 中和抗体的首次人体研究
- 批准号:
10550458 - 财政年份:2023
- 资助金额:
$ 41.55万 - 项目类别:
Antiviral treatment of BK polyomavirus reactivation
BK 多瘤病毒再激活的抗病毒治疗
- 批准号:
10730924 - 财政年份:2023
- 资助金额:
$ 41.55万 - 项目类别:
Treatment of Inflammatory Complications of Viral Pneumonia
病毒性肺炎炎症并发症的治疗
- 批准号:
10383991 - 财政年份:2022
- 资助金额:
$ 41.55万 - 项目类别:
HSV-1 Encoded MicroRNAs in the Pathogenesis and Treatment of Ocular Herpes
HSV-1 编码的 MicroRNA 在眼疱疹发病机制和治疗中的作用
- 批准号:
10569577 - 财政年份:2022
- 资助金额:
$ 41.55万 - 项目类别: